|
Volumn 46, Issue 12, 2011, Pages 5941-5948
|
Synthesis and biological evaluation of novel dimethyl[1,1′-biphenyl]- 2,2′-dicarboxylate derivatives containing thiazolidine-2,4-dione for the treatment of concanavalin A-induced acute liver injury of BALB/c mice
|
Author keywords
Anti inflammation; Bifendate; Hepatoprotective; Thiazolidine 2,4 dione
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 (2 BROMO 4 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (2 ETHOXY 4 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (2 FLUORO 4 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (2 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (2,4 DIBROMO 6 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (2,4 DICHLORO 6 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (3 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (4 CHLORO 2 FORMYLPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO [D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (4 FORMYL 2 METHOXYPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (4 FORMYL 2,6 DIMETHOXYPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (4 FORMYLPHENYL) 5 METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 (5 FORMYL 2 METHOXYPHENYL) 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [2 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [2 BROMO 4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [2,4 DIBROMO 6 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [2,4 DICHLORO 6 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [3 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL] 2 ETHOXYPHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL] 2 FLUOROPHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL] 2 METHOXYPHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL] 2,6 DIMETHOXYPHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [4 CHLORO 2 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL]PHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
5 [5 [(2,4 DIOXOTHIAZOLIDIN 5 YLIDENE)METHYL] 2 METHOXYPHENYL] 5' METHYL 7,7' DIMETHOXY 4,4' BIBENZO[D][1,3]DIOXOLE 5,5' DICARBOXYLATE;
CARBOXYLIC ACID DERIVATIVE;
CARRAGEENAN;
CONCANAVALIN A;
LIPOPOLYSACCHARIDE;
NITRIC OXIDE;
UNCLASSIFIED DRUG;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BAGG ALBINO MOUSE;
CONTROLLED STUDY;
DRUG INDUCED DISEASE;
DRUG SYNTHESIS;
HISTOPATHOLOGY;
IN VIVO STUDY;
LIVER INJURY;
LIVER PROTECTION;
MOUSE;
NONHUMAN;
PAW EDEMA;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BIPHENYL COMPOUNDS;
CELL LINE;
CONCANAVALIN A;
EDEMA;
FEMALE;
HEPATITIS, ANIMAL;
LIPOPOLYSACCHARIDES;
LIVER;
MACROPHAGES;
MALE;
MICE;
MICE, INBRED BALB C;
NITRIC OXIDE;
RATS;
|
EID: 80955136564
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2011.10.005 Document Type: Article |
Times cited : (9)
|
References (21)
|